Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2017
Patient Age-Associated Mortality Risk Is Differentiated by BRAF V600E Status in Papillary Thyroid CancerXiaopei Shen, Guangwu Zhu, Rengyun Liu, et al.European Journal of Cancer (Oxford, England : 1990)|December 3, 2019
BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinomaKyeong J Kim, Sin G Kim, Jie Tan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 3, 2018
BRAF V600E Confers Male Sex Disease-Specific Mortality Risk in Patients With Papillary Thyroid CancerFei Wang, Shihua Zhao, Xiaopei Shen, et al.Journal of the National Cancer Institute|November 23, 2017
BRAF V600E Mutation-Assisted Risk Stratification of Solitary Intrathyroidal Papillary Thyroid Cancer for Precision TreatmentYueye Huang, Shen Qu, Guangwu Zhu, et al.Hormone Research in Paediatrics|December 1, 2025
EndoCompass Project: Research Roadmap for Thyroid EndocrinologyAgnieszka Piekielko-Witkowska, Rossella Elisei, Juliane Léger, et al.The Journal of Clinical Endocrinology and Metabolism|July 17, 2021
BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid CancerYubing Tao, Fei Wang, Xiaopei Shen, et al.The Journal of Clinical Endocrinology and Metabolism|June 6, 2017
The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid CancerFei Wang, Xiaolong Yu, Xiaopei Shen, et al.The Lancet. Oncology|October 2, 2025
Genetic modification of the AJCC classification of papillary thyroid cancer: an international, multicentre, retrospective cohort studyMingzhao Xing, Shuhuang Lin, Aarti Mathur, et al.JAMA|April 11, 2013
Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancerMingzhao Xing, Ali S Alzahrani, Kathryn A Carson, et al.Human Mutation|October 28, 2010
Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10Karin Frank-Raue, Lisa A Rybicki, Zoran Erlic, et al.Pageof 5